Current disease status-First occurrence of the cancer - Page 3 of 58 Posts on Medivizor
Navigation Menu

Current disease status-First occurrence of the cancer Posts on Medivizor

Can stereotactic body radiotherapy can be used as an alternative to minimal invasive surgery for early-stage non-small cell lung cancer?

Can stereotactic body radiotherapy can be used as an alternative to minimal invasive surgery for early-stage non-small cell lung cancer?

Posted by on Apr 10, 2021 in Lung cancer | 0 comments

In a nutshell This article compared the use of video-assisted thoracoscopic lobectomy (VATL) versus stereotactic body radiotherapy (SBRT) for the treatment of early-stage non-small cell lung cancer (NSCLC). The authors found that SBRT could provide an alternative treatment option for these patients.  Some background Early-stage NSCLC is...

Read More

Comparing the safety outcomes between proton beam therapy vs intensity-modulated radiation therapy in early stage prostate cancer

Comparing the safety outcomes between proton beam therapy vs intensity-modulated radiation therapy in early stage prostate cancer

Posted by on Mar 31, 2021 in Prostate cancer | 0 comments

In a nutshell This study compared the safety outcomes between moderately-hypofractionated intensity-modulated radiation therapy (IMRT) and proton beam therapy (PBT) in patients with early-stage prostate cancer. The data showed that both treatments were safe and well-tolerated. Some background Radiation therapy (RT) is a treatment used for low- or...

Read More

Evaluating photoselective vaporization for urinary symptoms in patients with prostate cancer on active surveillance.

Evaluating photoselective vaporization for urinary symptoms in patients with prostate cancer on active surveillance.

Posted by on Mar 21, 2021 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients with prostate cancer with lower urinary tract symptoms (LUTS) during active surveillance. The results suggested that PVP treatment was safe and effective in these patients. Some background Active surveillance (AS)...

Read More

Urinary, sexual outcomes and tumor control after robot-assisted laparoscopic radical prostatectomy in localized prostate cancer

Urinary, sexual outcomes and tumor control after robot-assisted laparoscopic radical prostatectomy in localized prostate cancer

Posted by on Mar 14, 2021 in Prostate cancer | 0 comments

In a nutshell This study analyzed the urinary, sexual, and tumor control outcomes of robotic-assisted laparoscopic radical prostatectomy (RARP) over time in patients with localized prostate cancer. The study found that analyzing these three outcomes is beneficial for these patients. Some background Localized prostate cancer (PCa) is a form of...

Read More

Searching for patients with confined prostate cancer to trial a cryoablation procedure

Searching for patients with confined prostate cancer to trial a cryoablation procedure

Posted by on Mar 13, 2021 in Prostate cancer | 0 comments

In a nutshell This trial is looking to examine the use of a new treatment software (UroNAV Ablation) system in treating confined prostate cancer with cryoablation. The main outcomes to be measured will be device/treatment-related complications and tumor control. This trial is being carried out in New York, US.  The details Localized...

Read More

Comparing outcome in robotic-assisted versus laparoscopic prostate surgery

Comparing outcome in robotic-assisted versus laparoscopic prostate surgery

Posted by on Mar 10, 2021 in Prostate cancer | 0 comments

In a nutshell This study compared the effectiveness of functional and oncological outcomes of robotic-assisted (RA) and laparoscopic (Lap) radical prostatectomy (RP; removal of the prostate) in localized and locally advanced prostate cancer (PCa). the study concluded that RARP was similarly effective and had better urinary and sexual outcomes...

Read More

Can intraoperative radiotherapy be used to treat early-stage breast cancer?

Can intraoperative radiotherapy be used to treat early-stage breast cancer?

Posted by on Mar 6, 2021 in Breast cancer | 0 comments

In a nutshell This article looked at 5-year outcomes of intraoperative radiation therapy (IORT) for breast cancer (BC). The authors found that IORT may have a higher rate of cancer return compared to whole-breast radiation therapy (WBRT). Some background BC is one of the most common forms of cancer found in women. Standard care for BC is usually a...

Read More

Evaluating the use of radiotherapy followed by chemotherapy before surgery for locally-advanced rectal cancer.

Evaluating the use of radiotherapy followed by chemotherapy before surgery for locally-advanced rectal cancer.

Posted by on Feb 14, 2021 in Colorectal cancer | 0 comments

In a nutshell This trial looked at the use of short-course radiotherapy (RT) followed by chemotherapy (CT) and delayed surgery to reduce distant metastases (tumor spread) in patients with locally advanced rectal cancer (LARC). The trial found that this treatment was more effective in controlling distant metastases when compared to standard...

Read More

Comparing outcomes in single-port versus multiport robotic radical prostate surgery

Comparing outcomes in single-port versus multiport robotic radical prostate surgery

Posted by on Feb 13, 2021 in Prostate cancer | 0 comments

In a nutshell This study compared the surgical outcomes of patients undergoing single-port extraperitoneal prostatectomy (SP-EPP) with conventional multiport transperitoneal robot-assisted radical prostatectomy (MP-RARP). The data showed that the SP-EPP approach was associated with a shorter length of hospital stay as well as a reduction in pain...

Read More

Is chemotherapy beneficial for the treatment of patients with T1bN0M0 triple-negative breast cancer?

Is chemotherapy beneficial for the treatment of patients with T1bN0M0 triple-negative breast cancer?

Posted by on Jan 31, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the benefits of chemotherapy after surgery in patients with T1bN0M0 triple-negative breast cancer (TNBC). The data showed that chemotherapy after surgery resulted in similar outcomes as patients who did not undergo chemotherapy. Some background Triple-negative breast cancer (TNBC) is a subtype of breast...

Read More